Congenital Deafness and Goiter: Pendred Syndrome
|
|
- Clinton Gerard Short
- 8 years ago
- Views:
Transcription
1 This text is a translation from the original German which should be used for referencing. The German version is authoritative. REVIEW ARTICLE Congenital Deafness and Goiter: Pendred Syndrome Guntram Borck, Ulrike Napiontek, Nicole Pfarr, Wibke Müller-Forell, Annerose Keilmann, Joachim Pohlenz SUMMARY Introduction: Pendred syndrome is an autosomal recessive condition characterized by bilateral sensorineural deafness, vestibular and cochlear abnormalities, and goiter. The clinical course is extremely variable both in respect of hearing and of thyroid function. Methods: Selective review of articles on Medline retrieved using the search terms: Pendred, Pendred's, or SLC26A4, and mutation. Results: Pendred syndrome is caused by mutations in the SLC26A4 gene. It is a common cause of syndromic deafness as well as the second commonest cause of isolated deafness. Clinical genetic diagnosis allows identification of SLC26A4 mutations. Discussion: Despite being a common cause of congenital deafness, Pendred syndrome is probably underdiagnosed in Germany. Molecular analysis and thorough clinical assessment can confirm the diagnosis of Pendred syndrome. Treatment is largely symptomatic, and aims to optimize hearing and language development. Dtsch Arztebl 2006; 103(46): A Key words: Pendred syndrome, deafness, hypothyroidism, goiter, molecular genetics P endred syndrome consists of the combination of hearing impairment and euthyroid or hypothyroid goiter (1). Although this disease was described more than a hundred years ago, it remains unknown to most physicians in clinical practice, and its diagnosis is certainly often missed (2). A possible reason for this situation is the highly variable course of both the hearing impairment and the thyroid dysfunction. Though only about 10 families with Pendred syndrome have been identified in Germany in the literature published to date (3 6), it seems highly likely that there are more persons with this disease in Germany who would benefit from early diagnosis and treatment. Interestingly, two major clinical manifestations of Pendred syndrome, congenital hypothyroidism (frequency 1 : 4 000) and congenital hearing impairment (frequency approximately 1 to 2 : 2 000) can now be diagnosed in the neonatal period (7,8). The purpose of this review article is to describe the relevant considerations of diagnosis and treatment of this disease for physicians in clinical practice, while also discussing its molecular genetic and pathophysiological aspects. Methods This article is based upon published papers retrieved by a Medline search, which was last performed in January 2006, on the terms "Pendred," "Pendred's," or "SLC26A4" with either "mutation" or "mutations." Pendred syndrome definition and clinical features Pendred syndrome is inherited in an autosomal recessive pattern. Patients with the disease have disease-producing mutations in both copies of the relevant gene, while both parents are phenotypically normal, heterozygous carriers. Any child born to a pair of heterozygous carriers, whether male or female, has a 25% chance of having the disease. Pendred syndrome was first described in 1896 by the British general practitioner Vaughan Pendred ( ) (9). Its leading manifestation is hearing impairment, which is always bilateral, although one ear may be more severely affected than the other (10). The hearing impairment is of the sensorineural type and is usually severe, with a magnitude of at least INSERM U781, Hôpital Necker-Enfants Malades (Dr. med. Borck); Klinik und Poliklinik für HNO und Kommunikationsstörungen, Universitätskliniken der Johannes Gutenberg-Universität Mainz (Dr. med. Napiontek, Prof. Dr. med. Keilmann); Kinderklinik und -poliklinik, Universitätskliniken der Johannes Gutenberg-Universität Mainz (Dipl.-Biol. Pfarr, Prof. Dr. med. Pohlenz); Institut für Neuroradiologie, Universitätskliniken der Johannes Gutenberg-Universität Mainz (PD med. Müller-Forell) Dtsch Arztebl 2006; 103(46): A
2 DIAGRAM 1 Types of progression of hearing impairment in Pendred syndrome. The course of hearing impairment is shown for three patients, all siblings, who were homozygous for the identical mutation, designated T416P. A representative selection of audiograms is displayed for each of the three siblings over a 23-year course. To facilitate comparison, audiograms obtained at different ages are superimposed on each other in the same graph. The graph on the left for each patient represents the right ear, and vice versa. For Patients 1 and 2, the first audiogram (red) was a free-field reaction audiogram and appears on the left side of the figure. All of the other audiograms displayed here were pure-tone audiograms obtained from the two ears separately. Hearing impairment took a variable course in these three patients despite their common genotype: it was severe and progressive in Patient 1, severe but not progressive in Patient 2, and least severe initially, but with later, marked worsening, in Patient 3. Figure from Napiontek et al. (5). Copyright 2004, The Endocrine Society. Reprinted with permission. Dtsch Arztebl 2006; 103(46): A
3 BOX Diagnostic criteria for Pendred syndrome Disease-producing mutations in both alleles of the SLC26A4/PDS gene in a person with hearing impairment and thyroid pathology (goiter and/or hypothyroidism) are considered conclusive evidence of Pendred syndrome. The great majority (>80%) of patients with Pendred syndrome have the following: Bilateral sensorineural hearing impairment (100%) Enlarged vestibular aqueduct (CT or MRI of the petrous bones) Pathological perchlorate discharge test (PDT) Most (>50%) patients with Pendred syndrome have the following: Eu- or hypothyroid goiter Elevated serum thyroglobulin concentration A rarer finding: Mondini deformity: enlarged vestibular aqueduct and hypoplastic cochlea (CT or MRI of the petrous bones) 60 decibels (db). It is usually already present at birth and thus typically comes to medical attention through the absence or marked delay of language development (so-called prelingual hearing impairment). In rare cases, an affected child may undergo normal or only mildly delayed language development, so that the hearing impairment is not diagnosed till early childhood or even later. The hearing impairment of Pendred syndrome involves all frequencies, but the higher frequencies are usually more severely affected (10) (diagram 1). The course of the hearing impairment is variable. It tends to take one of the following three forms: 1. The hearing impairment remains stable for several years 2. It fluctuates in severity, with episodes of sudden worsening and of partial or complete remission 3. It progresses in severity, ending as bilateral deafness. The cause of this phenotypic variability has not yet been determined. It has been found that the hearing impairment may take a different course in two affected siblings with identical molecular genetic defects (5) (diagram 1). In addition to hearing impairment, the other characteristic feature of Pendred syndrome is thyroid involvement, with goiter and hypothyroidism (1, 11). A defect of thyroid hormone synthesis impairs the transport of iodide from thyroid cells into the colloid. Unlike the hearing impairment, which is always present, the thyroid abnormality is of highly variable severity, especially in children; it may be absent when the hearing impairment is first diagnosed. Although neonates with Pendred syndrome rarely have an enlarged thyroid gland, approximately 75% of affected persons will eventually develop a multinodular or diffuse goiter (11). Sometimes the goiter must be surgically resected at some point in the course of the disease because of tracheal compression. It remains unknown why the goiter often does not appear till late childhood, adolescence, or early adulthood. Diagnostic evaluation Pendred syndrome is diagnosed on clinical grounds alone, because no simple laboratory test for the disease is available. The diagnosis of Pendred syndrome should be considered in all patients suffering from a bilateral sensorineural deafness in combination with goiter, Dtsch Arztebl 2006; 103(46): A
4 a Figure An enlarged vestibular aqueduct: the typical inner ear malformation associated with Pendred syndrome. Neuroradiological depictions of bilateral enlarged vestibular aqueducts (EVAs) in patients with Pendred syndrome: high-resolution CT (a, b) and MRI (c, d). The arrows point to enlargements in the vestibular aqueducts. The star in (d) indicates an additional ampullary cyst in the cerebellopontine angle. Figure from Napiontek et al. (5). Copyright 2004, The Endocrine Society. Reprinted with permission. b c d Dtsch Arztebl 2006; 103(46): A
5 DIAGRAM 2 Synthetic pathway of thyroid hormone. Schematic, markedly simplified depiction of a thyroid cell and thyroid hormone synthesis. hypothyroidism, and/or a congenital anomaly of the inner ear (see box). Precise historytaking and meticulous physical examination are essential if the diagnosis is not to be missed. An extensive family history should be elicited, because, as in other autosomal recessive forms of congenital deafness, the diagnosis is more likely if the parents are consanguineous or if one or more siblings are already known to be affected. The child's hearing, language skills, and psychomotor development should also be taken into account. If the child has an enlarged thyroid gland or manifestations of hypothyroidism, further studies should be performed, in a manner appropriate to his or her age and developmental level. These include both subjective audiometric testing (reflex, reaction, pure tone, and speech audiometry) and electrophysiological testing to determine the auditory threshold, e.g., the measurement of otoacoustic emissions and the recording of brainstem auditory evoked potentials. Nearly all patients with Pendred syndrome have a congenital inner ear anomaly (12). High-resolution imaging of the petrous bones with computed tomography (CT) or magnetic resonance tomography (MRT) reveals an enlarged vestibular aqueduct (EVA) in 85% to 100% of cases (figure a d). Approximately 20% of all patients also have an anomalously formed, hypoplastic cochlea, the so-called Mondini deformity. The presence of an EVA in a hearing-impaired child should always lead to the inclusion of Pendred syndrome in the differential diagnosis, even though EVA is the most common neuroradiological finding in children with sensorineural hearing impairment and is not specific for Pendred syndrome. Nor has any correlation been demonstrated to date between the presence and extent of an EVA and the severity of hearing impairment. If Pendred syndrome is suspected on clinical grounds, the patient's thyroid function should be checked. The most important thyroid parameters are the serum concentrations of thyroid-stimulating hormone (TSH) and free thyroxine (ft4) (11). The hypothyroidism associated with Pendred syndrome is of the primary type, i.e., the disturbance of thyroid hormone biosynthesis is located in the thyroid gland itself and is not due to dysfunction of the hypothalamic pituitary axis (11, 13). Thus, the ft4 concentration is low and the TSH concentration is elevated. Newborn infants with Pendred syndrome are often still euthyroid; only a few cases have reported to date in which Pendred syndrome was diagnosed in the neonatal period (11). In some patients, the hypothyroidism is compensated, i.e., the thyroid gland, under the influence of an increased amount of TSH, is still able to produce enough thyroid hormone to sustain a euthyroid metabolic state. As in other deficiencies of thyroid hormone synthesis, the serum thyroglobulin concentration is often elevated; this may be an important clue to the differential diagnosis. Dtsch Arztebl 2006; 103(46): A
6 Finally, thyroid ultrasonography allows a lobe-by-lobe determination of thyroid volume as well as visualization of any cysts that may be present. It facilitates the diagnostic distinction between Pendred syndrome and inflammatory or malignant diseases of the thyroid gland. The available literature provides insufficient information to determine whether the goiter associated with Pendred syndrome is a risk factor for malignant degeneration. It should be mentioned, however, that a small number of cases have been reported in which malignant thyroid tumors arose in goiters of patients with Pendred syndrome (14). This is a further reason why the thyroid gland should be periodically followed up with ultrasonography. The perchlorate discharge test (PDT) was long considered to be the most important criterion for the diagnosis of Pendred syndrome (1). It is used to demonstrate the presence of an iodide organification defect in the thyroid gland. Radioactively labeled iodine is administered, followed by perchlorate, which displaces iodine, in order to determine whether the thyroid gland fixes iodine adequately. In Pendred syndrome, as in other defects of thyroid hormone synthesis, the test is typically positive, i.e., the thyroid gland does not adequately incorporate the radiolabeled iodine into thyroid hormone molecules. Until a few years ago, the triad of congenital bilateral sensorineural hearing impairment, goiter, and positive PDT was thought to constitute proof of the diagnosis of Pendred syndrome. The PDT, however, is neither 100% specific nor 100% sensitive, and the great majority of patients and their parents will not allow it to be performed in any case. This test, therefore, is increasingly being replaced by molecular genetic analysis. Molecular diagnosis of Pendred syndrome has been available since 1997 and is based on sequence analysis of the Pendred syndrome gene (PDS/SLC26A4), which can be performed from an EDTA blood sample. If the patient is found to possess two mutations of this gene that are already known to cause disease (homozygote or compound heterozygote), the diagnosis is established. It remains possible, however, that only one mutation will be found, i.e., that the patient will be found to be a heterozygote. In this case, the patient has Pendred syndrome only if the second allele contains a cryptic mutation or deletion, i.e., one that cannot be identified on routine testing. Finally, there are rare, usually sporadic cases of Pendred syndrome in which no mutations are found. This implies that other genetic causes of Pendred syndrome may exist beyond the single Pendred syndrome gene that has been identified to date. The effective diagnosis and optimal treatment of patients with Pendred syndrome requires the interdisciplinary collaboration of pediatricians, endocrinologists, geneticists, phoniatrists/ pediatric audiologists, ENT specialists, and neuroradiologists. Differential diagnosis The hearing impairment and thyroid abnormalities of Pendred syndrome each have their own differential diagnosis, as will be discussed in this section. Hearing impairment and goiter are common problems in themselves, and their joint appearance in a single patient does not necessarily imply the presence of Pendred syndrome. If a patient suffers from hearing impairment of unknown etiology, non-genetic causes should be excluded first (15). These include intrauterine infection (e.g., toxoplasmosis, rubella, and cytomegalovirus infection), premature birth, perinatal asphyxia, and the ototoxic side effects of postnatally administered medications, particularly aminoglycoside antibiotics and cytostatic agents. Approximately 50% to 60% of all cases of permanent hearing impairment arising in childhood are due to genetic defects (16). There are syndromal forms associated with dysfunction or congenital defects of other organs, as well as non-syndromal (isolated) hearing impairment. An article by Kubisch that previously appeared in this journal dealt with the genetic causes of non-syndromal hearing impairment (17). That article discussed the important role of the connexins, particularly connexin 26, which is the most commonly mutated gene causing hearing impairment (18). The first task in clinical diagnosis is, therefore, to determine whether the hearing impairment is syndromal or non-syndromal. If goiter or hypothyroidism is found, the possibility of Pendred syndrome should be suspected. If the patient is then determined to have the typical complex of disease manifestations (congenital bilateral hearing impairment with enlarged vestibular aqueduct and goiter or a pathological perchlorate discharge test), the diagnosis of Pendred syndrome is highly likely and molecular genetic testing should be recommended. Mutations of the Pendred syndrome gene, however, are also a common cause Dtsch Arztebl 2006; 103(46): A
7 GRAFIK 3 PDS/SLC26A4 mutations and Pendred syndrome. Schematic depiction of the pendrin molecule. The stars indicate the sites of the more common mutations of the pendrin protein. The red stars indicate the mutation sites that are most commonly identified worldwide (L236P, IVS8+1g>a, T416P, H723R), while the blue stars indicate those that have been published to date for German families with Pendred syndrome (3 6). of isolated hearing impairment; thus, the lack of other clinical signs of the disease does not rule out this diagnosis. Pendred syndrome may also be diagnosed from the other direction, i.e., in a child who initially comes to medical attention because of thyroid abnormalities, which may be of highly variable severity. The differential diagnostic considerations in this situation are as follows. The commonest cause of goiter worldwide is iodine deficiency (7). In a child with goiter, other disturbances of thyroid hormone synthesis should also be included in the differential diagnosis, as well as inflammatory and malignant diseases of the thyroid gland. Pendred syndrome is sometimes hard to distinguish from other causes of disturbed thyroid hormone synthesis, but most of these other causes are not associated with deafness (19). If an inflammatory or malignant disease of the thyroid gland is present, then further laboratory tests are required (e.g., antithyroid antibodies, tumor markers), as well as thyroid ultrasonography and scintigraphy. Molecular genetics and pathophysiology Almost exactly 100 years after the first clinical description of Pendred syndrome, the responsible gene for it was found on chromosome 7 the PDS gene, or SLC26A4, as it is now officially called (26). This gene is expressed in the thyroid gland, the inner ear, and the kidney. The gene product, a protein called pendrin, functions as an iodide transporter from within thyroid cells into the colloid, in which thyroid hormone is synthesized (diagram 2). Mutations in both alleles of this gene cause Pendred syndrome (3 6, 20). More than 90 mutations in the SLC26A4 gene that cause Pendred syndrome have been identified to date (diagram 3). Only eight of the mutations found in Germany have been published (3 6). One of these mutations, V138F, seems to be more common in Germany than elsewhere (4). In rarer cases, SLC26A4 mutations can also cause isolated hearing impairment with EVA but without thyroid involvement (21). In vitro studies have shown that goiter in Pendred syndrome is caused by the lack of pendrin protein function. It has been demonstrated that a number of SLC26A4 mutations result in the synthesis of altered pendrin proteins that are abnormally distributed within the thyroid cells. Rather than being incorporated into the cell membrane, where pendrin normally carries out its function, these mutated pendrin molecules remain in the endoplasmic reticulum (22). This leads to a diminished amount of iodide transport into the thyrocolloid and thus to diminished T3 and T4 synthesis, hypothyroidism, and goiter. Dtsch Arztebl 2006; 103(46): A
8 Treatment Pendred syndrome is treated symptomatically. The goal of treatment is to enable the hearing and speech of affected children to develop as normally as possible. There have been no controlled studies of treatment, as this is a rare disease. It seems reasonable to assume, however, that the affected children stand to benefit from the early provision of hearing aids and special education. Early diagnosis is very important so that this can be achieved. Regular follow-up testing of audition is recommended so that progressive worsening can be detected, if present, and hearing aids can be accordingly optimized. Finally, for patients with bilateral deafness, cochlear implant surgery is indicated (23). If hypothyroidism is present, the patient should be treated at once with thyroid hormone substitution to enable normal mental and physical development. This treatment also has a favorable effect on the size of the thyroid gland. Sometimes the size of the thyroid fails to change favorably despite substitution therapy, either because of faulty compliance or for other, unknown reasons. Therefore, close follow-up is required, particularly in adolescent patients. Summary and future perspectives Pendred syndrome is a common type of syndromal hearing impairment, and mutations of the SLC26A4 gene are the second most common cause of non-syndromal hearing impairment (24, 25). Molecular genetic analysis enables the identification of SLC26A4 mutations in both alleles of the gene in affected persons, providing conclusive proof of the diagnosis. Early diagnosis is of great importance to the treating physician and the affected patients, so that measures can be taken immediately to enable hearing and language to develop as normally as possible. Early diagnosis is also promoted by attentiveness to children's hearing and language function on the part of parents and day-care or school personnel. If a problem in these areas is suspected, an audiological examination should be performed. Whenever hearing impairment is documented, the child's thyroid function should also be tested, so that thyroid hormone substitution, if it is needed, can be begun as soon as possible. In the future, it would be desirable to have molecular genetic studies that would yield prognostic information about the probable course of the disease and that would enable further improvements in its treatment. To this end, the clinical course of Pendred syndrome should be studied and correlated with the molecular genetic findings in as many patients as possible who suffer from this disease. Conflict of Interest Statement The authors declare that no conflict of interest exists according to the Guidelines of the International Committee of Medical Journal Editors. Manuscript received on 6 September 2005, final version accepted on 17 March Translated from the original German by Ethan Taub, M.D. REFERENCES 1. Reardon W, Trembath RC: Pendred syndrome. J Med Genet 1996; 33: Reardon W, Coffey R, Phelps PD et al.: Pendred syndrome 100 years of underascertainment? QJM 1997; 90: Coyle B, Reardon W, Herbrick JA et al.: Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet 1998; 7: Borck G, Roth C, Martine U, Wildhardt G, Pohlenz J: Mutations in the PDS gene in German families with Pendred's syndrome: V138F is a founder mutation. J Clin Endocrinol Metab 2003; 88: Napiontek U, Borck G, Müller-Forell W et al.: Intrafamilial variability of the deafness and goiter phenotype in Pendred syndrome caused by a T416P mutation in the SLC26A4 gene. J Clin Endocrinol Metab 2004; 89: Birkenhäger R, Knapp FB, Klenzner T, Aschendorff A, Schipper J: Identifizierung von zwei heterozygoten Mutationen im SLC26A4/PDS-Gen einer Familie mit Pendred-Syndrom. Laryngo-Rhino-Otologie 2004; 83: Roberts CG, Ladenson PW: Hypothyroidism. Lancet 2004; 363: Thompson DC, McPhillips H, Davis RL, Lieu TL, Homer CJ, Helfand M: Universal newborn hearing screening: summary of evidence. JAMA 2001; 286: Pendred V: Deaf-mutism and goitre. Lancet 1896; ii: Luxon LM, Cohen M, Coffey RA et al.: Neuro-otological findings in Pendred syndrome. Int J Audiol 2003; 42: Dtsch Arztebl 2006; 103(46): A
9 This text is a translation from the original German which should be used for referencing. The German version is authoritative. 11. Reardon W, Coffey R, Chowdhury T et al.: Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J Med Genet 1999; 36: Phelps PD, Coffey RA, Trembath RC et al.: Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998; 53: Kopp P: Pendred's syndrome and genetic defects in thyroid hormone synthesis. Rev Endocr Metab Disord 2000; 1: Camargo R, Limbert E, Gillam M et al.: Aggressive metastatic follicular thyroid carcinoma with anaplastic transformation arising from a long-standing goiter in a patient with Pendred's syndrome. Thyroid 2001; 11: Smith RJH, Bale JF, White KR: Sensorineural hearing loss in children. Lancet 2005; 365: Cryns K, Van Camp G: Deafness genes and their diagnostic applications. Audiol Neurootol 2004; 9: Kubisch C: Genetische Grundlagen nichtsyndromaler Hörstörungen. Dtsch Arztebl 2005; 102: A Smith RJ, Robin NH: Genetic testing for deafness GJB2 and SLC26A4 as causes of deafness. J Commun Disord 2002; 35: Park SM, Chatterjee VK: Genetics of congenital hypothyroidism. J Med Genet 2005; 42: Everett LA, Glaser B, Beck JC et al.: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997; 17: Pryor SP, Madeo AC, Reynolds JC et al.: SLC26A4/PDS geno-type-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 2005; 42: Rotman-Pikielny P, Hirschberg K, Maruvada P et al.: Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum Mol Genet 2002; 11: Vescan A, Parnes LS, Cucci RA, Smith RJ, MacNeill C: Cochlear implantation and Pendred's syndrome mutation in monozygotic twins with large vestibular aqueduct syndrome. J Otolaryngol 2002; 31: Park HJ, Shaukat S, Liu XZ et al.: Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: Global implications for the epidemiology of deafness. J Med Genet 2003; 40: Hutchin T, Coy NN, Conlon H et al.: Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK implications for genetic testing. Clin Genet 2005; 68: Corresponding author Prof. Dr. med. Joachim Pohlenz Kinderklinik und -poliklinik Universitätsklinik der Johannes-Gutenberg-Universität Mainz, Germany Dtsch Arztebl 2006; 103(46): A
G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics
G. Shashidhar Pai, MD MUSC Children s Hospital Department of Pediatrics Division of Genetics One of every 500 newborns has bilateral permanent sensorineural hearing loss 40 db which makes it the most common
More informationPatient Information. for Childhood
Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood
More informationBEST PRACTICES Pediatric Bilateral Sensorineural Hearing Loss
BEST PRACTICES Pediatric Bilateral Sensorineural Hearing Loss Christina L. Runge, PhD, CCC-A Associate Professor Chief, Division of Communication Sciences Director, Koss Cochlear Implant Program Resources
More informationJennifer A. Defant, M.S., C.G.C. Certified Genetic Counselor Division of Genetics and Metabolism University of Florida
Jennifer A. Defant, M.S., C.G.C. Certified Genetic Counselor Division of Genetics and Metabolism University of Florida 60% of childhood hearing loss is genetic Syndromic Nonsyndromic 40% of childhood hearing
More informationDURATION OF HEARING LOSS
When your child is diagnosed with a hearing loss, it may be very overwhelming. This may be a difficult time for you and your family. However, gaining a greater knowledge in this area is crucial in helping
More informationHypothyroidism. Written by Donald Yung Edited by Dianna Louie. Basic Embryology and Anatomy
Hypothyroidism Written by Donald Yung Basic Embryology and Anatomy The thyroid gland consists of two lobes connected by an isthmus and is located anterior to the trachea at the base of the neck. During
More informationTitle: Genetics and Hearing Loss: Clinical and Molecular Characteristics
Session # : 46 Day/Time: Friday, May 1, 2015, 1:00 4:00 pm Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Presenter: Kathleen S. Arnos, PhD, Gallaudet University This presentation
More informationAbout The Causes of Hearing Loss
About 1 in 500 infants is born with or develops hearing loss during early childhood. Hearing loss has many causes: some are genetic (that is, caused by a baby s genes) or non-genetic (such as certain infections
More informationObjectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL
Objectives Role of Medical Genetics in Hearing Loss Evaluation Millan Patel, MD UBC Dept. of Medical Genetics October 22, 2010 Case presentation to illustrate importance of defining syndromic hearing loss
More informationWhy does my child have a hearing loss?
Introduction This factsheet will tell you about the range of tests that can be carried out to try to find the cause of your child s hearing loss. The process to find out why a child is deaf is sometimes
More informationCOCHLEAR NERVE APLASIA : THE AUDIOLOGIC PERSPECTIVE A CASE REPORT. Eva Orzan, MD Pediatric Audiology University Hospital of Padova, Italy
COCHLEAR NERVE APLASIA : THE AUDIOLOGIC PERSPECTIVE A CASE REPORT Eva Orzan, MD Pediatric Audiology University Hospital of Padova, Italy Congenital absence or underdevelopment of the cochlear nerve has
More informationCONGENITAL HEARING LOSS
CONGENITAL HEARING LOSS Congenital hearing loss, for the purposes of this fact sheet, is defined as permanent and is bilateral or unilateral, is sensory or conductive, and averages 30 db or more in the
More informationHypothyroidism clinical features and treatment. 1. The causes of hypothyroidism
Hypothyroidism clinical features and treatment 1. The causes of hypothyroidism The thyroid is a gland in the neck which makes two thyroid hormones, thyroxine (T4) and tri-iodothyronine (T3). Thyroxine
More informationCorporate Medical Policy Genetic Testing for Hereditary Hearing Loss
Corporate Medical Policy Genetic Testing for Hereditary Hearing Loss File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_hereditary_hearing_loss 10/2013 8/2015 8/2016
More informationOrdering and interpreting thyroid tests in children. Paul Kaplowitz, MD, PhD Children s National Medical Center, Washington, DC
Ordering and interpreting thyroid tests in children Paul Kaplowitz, MD, PhD Children s National Medical Center, Washington, DC Objectives To review indications for thyroid testing To discuss which tests
More informationHearing Screening Coding Fact Sheet for Primary Care Pediatricians
Hearing Screening Coding Fact Sheet for Primary Care Pediatricians While coding for hearing screening is relatively straightforward, ensuring that appropriate payment is received for such services is a
More informationCoding Fact Sheet for Primary Care Pediatricians
1/1/2015 Hearing Testing Coding Fact Sheet Coding Fact Sheet for Primary Care Pediatricians While coding for hearing screening is relatively straightforward, ensuring that appropriate payment is received
More informationUsher Syndrome Genetics
Usher Syndrome Genetics October 2012 Page 1 of 20 Introduction Usher syndrome is a genetic or inherited condition that affects hearing, vision and balance The sight loss is caused by an eye condition known
More informationQuestions and Answers for Parents
Questions and Answers for Parents There are simple, inexpensive tests available to detect hearing impairment in infants during the first days of life. In the past, most hearing deficits in children were
More information1/26/2011. 50% of deafness and hearing impairment is avoidable through prevention, early diagnosis, and management.
Hearing Impairment Roseann Mulligan, DDS, MS Herman Ostrow School of Dentistry of the University of Southern California 1 JAMA, July 4, 2007 Vol 298, No. 1 2 278 million - moderate to profound bilateral
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationGONCA SENNAROĞLU PhD LEVENT SENNAROĞLU MD. Department of Otolaryngology Hacettepe University ANKARA, TURKEY
GONCA SENNAROĞLU PhD LEVENT SENNAROĞLU MD Department of Otolaryngology Hacettepe University ANKARA, TURKEY To present the audiological findings and rehabilitative outcomes of CI in children with cochlear
More informationA Parent s Guide to Understanding Congenital Hypothyroidism. Children s of Alabama Department of Pediatric Endocrinology
A Parent s Guide to Understanding Congenital Hypothyroidism Children s of Alabama Department of Pediatric Endocrinology How did you get here? Every baby born in the state of Alabama is required by law
More informationEXECUTIVE SUMMARY OF JOINT COMMITTEE ON INFANT HEARING YEAR 2007 POSITION STATEMENT. Intervention Programs
EXECUTIVE SUMMARY OF JOINT COMMITTEE ON INFANT HEARING YEAR 2007 POSITION STATEMENT Principles and Guidelines for Early Hearing Detection and Intervention Programs The Joint Committee on Infant Hearing
More informationCongenital Hearing Loss
Congenital Hearing Loss A resident asks... Why would a primary care physician want to know about the genetics of hearing loss? Key Points: Newborn screening for hearing loss is being implemented in many
More informationGenetic Bases of Hearing Loss: Future Treatment Implications
Genetic Bases of Hearing Loss: Future Treatment Implications Luis F. Escobar, MD Medical Director Medical Genetics & Neurodevelopmental Pediatrics of Indiana Peyton Manning Children s Hospital St. Vincent
More informationGenetic Aspects of Mental Retardation and Developmental Disabilities
Prepared by: Chahira Kozma, MD Associate Professor of Pediatrics Medical Director/DCHRP Kozmac@georgetown.edu cck2@gunet.georgetown.edu Genetic Aspects of Mental Retardation and Developmental Disabilities
More informationUnderstanding Hearing Loss 404.591.1884. www.childrensent.com
Understanding Hearing Loss 404.591.1884 www.childrensent.com You just found out your child has a hearing loss. You know what the Audiologist explained to you, but it is hard to keep track of all the new
More informationHearing Tests for Children with Multiple or Developmental Disabilities by Susan Agrawal
www.complexchild.com Hearing Tests for Children with Multiple or Developmental Disabilities by Susan Agrawal Hearing impairment is a common problem in children with developmental disabilities or who have
More informationSo, how do we hear? outer middle ear inner ear
The ability to hear is critical to understanding the world around us. The human ear is a fully developed part of our bodies at birth and responds to sounds that are very faint as well as sounds that are
More informationThe Role of the Educational Audiologist 2014. Introduction:
The Role of the Educational Audiologist 2014. Introduction: As the current CHAIR of the BAEA I felt that it was time for the Role of the Educational Audiologist to be updated. There has been a period of
More informationHEARING & HEARING LOSS. Dr I Butler 2015
HEARING & HEARING LOSS Dr I Butler 2015 DISCLOSURE Sponsorship to attend local and international workshops Cochlear (Southern ENT) Med el TOPICS Anatomy Classification of hearing loss Congenital hearing
More informationAcute Profound Deafness
Sensory Organ Disorders Acute Profound Deafness How much do we now know about the clinical condition? JMAJ 46(7): 285 290, 2003 Jin KANZAKI Director, International University of Health and Welfare Atami
More informationCOCHLEAR IMPLANTATION IN A PATIENT WITH LARGE VESTIBULAR AQUEDUCT SYNDROME: A CASE REPORT GENİŞ VESTİBÜLER SENDROMLU HASTADA KOKLEAR İMPLANTASYON
CASE REPORT COCHLEAR IMPLANTATION IN A PATIENT WITH LARGE VESTIBULAR AQUEDUCT SYNDROME: A CASE REPORT Ufuk Derinsu, Ayça Çiprut, Sezer Külekçi, Ferda Akdaş Sub-department of Audiology, Department of Otorhinolaryngology,
More information95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in
James Whale Fund for Kidney Cancer Childhood kidney cancer factsheet Kidney cancer rarely afflicts children and about 90 paediatric cases are diagnosed in the UK each year. About 75% of childhood kidney
More informationGuidance on professional practice for Hearing Aid Audiologists
Guidance on professional practice for Hearing Aid Audiologists Assuring High Quality Professional Hearing Care Introduction This booklet is intended to be guidance on good professional practices for Registered
More informationOriginal Article. Abstract. Introduction: Nazia M 1, Sadaf N 2, Saima T 3
Original Article Trends For Investigations Carried Out For Detection Of Severe To Profound Hearing Impairment For Children In Pakistan Nazia M 1, Sadaf N 2, Saima T 3 Abstract Background: Hearing impairment
More informationCerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments.
The Face of Cerebral Palsy Segment I Discovering Patterns What is Cerebral Palsy? Cerebral palsy (CP) is an umbrella term for a group of non-progressive but often changing motor impairment syndromes, which
More informationDIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES
DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES Extracts from a review article by KN North and KJ Jones: Recent advances in diagnosis of the childhood muscular dystrophies Journal of Paediatrics and Child Health
More informationHearing Aids - Adult HEARING AIDS - ADULT HS-159. Policy Number: HS-159. Original Effective Date: 3/18/2010. Revised Date(s): 3/18/2011; 3/1/2012
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationPediatric Hearing Assessment
Pediatric Hearing Assessment Stanton Jones Key Points This chapter outlines the methods of hearing assessment that are appropriate for children from birth to adolescence. The importance of timely referral
More informationGenetic Testing for Hereditary Hearing Loss
MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDIX HISTORY Genetic Testing for Hereditary Hearing Loss Number 12.04.87 Effective
More informationSENSORINEURAL HEARING LOSS INVESTIGATION & REFERRAL
Epidemiology NZ Hearing Screening Referral Pathway Important Services When to Investigate Initial Assessment Referrals Investigations Indications for Cochlear Transplant Acknowledgements References Epidemiology
More informationloving life YOUR GUIDE TO YOUR THYROID
loving life YOUR GUIDE TO YOUR THYROID one THE THYROID two HYPOTHYROIDISM three HYPERTHYROIDISM four TREATING HYPERTHYROIDISM five THYROID NODULES AND GOITRES one THE THYROID What is the thyroid? The thyroid
More informationMendelian inheritance and the
Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate
More informationDiagnostic Scoring System for LQTS
Medical Coverage Policy Genetic Testing: Congenital Long QT Syndrome Device/Equipment Drug Medical Surgery Test Other Effective Date: 2/15/2011 Policy Last Updated: 2/21/2012 Prospective review is recommended/required.
More informationNORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
More informationManagement and Treatment Guidelines for Cornelia de Lange Syndrome
Management and Treatment Guidelines for Cornelia de Lange Syndrome These cards highlight routine care for people with CdLS needed by specific age groups, including infancy, early and late childhood, adolescence
More informationAudio Examination. Place of Exam:
Audio Examination Name: Date of Exam: SSN: C-number: Place of Exam: The Handbook of Standard Procedures and Best Practices for Audiology Compensation and Pension Exams is available online. ( This is a
More informationThe Developing Person Through the Life Span 8e by Kathleen Stassen Berger
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington
More informationLearners Who are Deaf or Hard of Hearing Kalie Carlisle, Lauren Nash, and Allison Gallahan
Learners Who are Deaf or Hard of Hearing Kalie Carlisle, Lauren Nash, and Allison Gallahan Definition Deaf A deaf person is one whose hearing disability precludes successful processing of linguistic information
More informationDevelopmental delay and Cerebral palsy. Present the differential diagnosis of developmental delay.
Developmental delay and Cerebral palsy objectives 1. developmental delay Define developmental delay Etiologies of developmental delay Present the differential diagnosis of developmental delay. 2. cerebral
More informationIs Hypothyroidism a Cause of Ovarian Cysts?- This Unusual Case Depicts So
Article ID: WMC001641 ISSN 2046-1690 Is Hypothyroidism a Cause of Ovarian Cysts?- This Unusual Case Depicts So Corresponding Author: Prof. Rajiv R Mahendru, Consultant, Obs Gyn, MMIMSR, 134003 - India
More informationCommunicating with Families about Family History and Genetics
Communicating with Families about Family History and Genetics Abdallah F. Elias, M.D. Providence Genetics Clinic at Grant Creek & Florence Family Practice Department of Biomedical and Pharmaceutical Sciences
More informationAGE Iowa Midwest Nation N % N % N % Total students 256 100.0 9272 100.0 37500 100.0 Information NOT reported 7 2.7 229 2.5 841 2.2
202-651-5575 * 1-800-451-8834 ext 5575 Page 1 of 9 AGE Iowa Midwest Nation Information NOT reported 7 2.7 229 2.5 841 2.2 Total known information 249 100.0 9043 100.0 36659 100.0 Under 3 years 16 6.4 201
More informationTHYROID FUNCTION TESTS
Thyroid Stimulating Hormone (TSH): THYROID FUNCTION TESTS The thyroid stimulating hormone (TSH) assay measures the concentration of thyroid stimulating hormone in the serum. TSH assays have been classified
More informationF r e q u e n t l y A s k e d Q u e s t i o n s
Myasthenia Gravis Q: What is myasthenia gravis (MG)? A: Myasthenia gravis (meye-uhss- THEEN-ee-uh GRAV uhss) (MG) is an autoimmune disease that weakens the muscles. The name comes from Greek and Latin
More informationNew Estimates of the Economic Benefits of Newborn Screening for Congenital Hypothyroidism in the US
The findings and conclusions in this presentation have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination
More informationNEW JERSEY ADMINISTRATIVE CODE TITLE 8. DEPARTMENT OF HEALTH AND SENIOR SERVICES CHAPTER 19. NEWBORN SCREENING PROGRAM
NEW JERSEY ADMINISTRATIVE CODE TITLE 8. DEPARTMENT OF HEALTH AND SENIOR SERVICES CHAPTER 19. NEWBORN SCREENING PROGRAM AUTHORITY N.J.S.A. 26:2-101 et seq., 26:2-110 and 26:2-111 SOURCE AND EFFECTIVE DATE
More informationLecture 3: Mutations
Lecture 3: Mutations Recall that the flow of information within a cell involves the transcription of DNA to mrna and the translation of mrna to protein. Recall also, that the flow of information between
More informationNeurofibromatosis Type 2: Information for Patients & Families by Mia MacCollin, M.D., Catherine Bove, R.N. Ed. & M. Priscilla Short, M.D.
Neurofibromatosis Type 2: Information for Patients & Families by Mia MacCollin, M.D., Catherine Bove, R.N. Ed. & M. Priscilla Short, M.D. Neurofibromatosis Type 2 is a rare genetic disease, which causes
More informationSection 4. Hearing loss and hearing tests
Section 4 Hearing loss and hearing tests How we hear Outer Ear Middle Ear Inner Ear 4. 7. 8. 1. 3. 6. 2. 5. 1. 2. 3. 4. 5. 6. 7. 8. Ear canal Ear drum Middle ear cavity Middle ear bones the malleus, incus,
More information8.Audiological Evaluation
8. A U D I O L O G I C A L E V A L U A T I O N 8.Audiological Evaluation The external ear of the child with Progeria Behavioral testing for assessing hearing thresholds Objective electrophysiologic tests
More informationCHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA
CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Cytogenetics is the study of chromosomes and their structure, inheritance, and abnormalities. Chromosome abnormalities occur in approximately:
More informationEnlarged Vestibular Aqueduct Syndrome
PO BOX 13305 PORTLAND, OR 97213 FAX: (503) 229-8064 (800) 837-8428 INFO@VESTIBULAR.ORG WWW.VESTIBULAR.ORG Enlarged Vestibular Aqueduct Syndrome (EVAS) By Hamid, MD, PhD, EE, The Cleveland Hearing & Balance
More informationOAE hearing screening at your fingertips OAE+
OAE hearing screening at your fingertips OAE+ Periodic hearing screening leads to early detection of hearing loss 6-7 per 1000 children will be identified with permanent hearing loss in early childhood.
More informationChromosomes, Mapping, and the Meiosis Inheritance Connection
Chromosomes, Mapping, and the Meiosis Inheritance Connection Carl Correns 1900 Chapter 13 First suggests central role for chromosomes Rediscovery of Mendel s work Walter Sutton 1902 Chromosomal theory
More informationDr. Abdel Aziz Hussein Lecturer of Physiology Mansoura Faculty of Medicine
Physiological Basis of Hearing Tests By Dr. Abdel Aziz Hussein Lecturer of Physiology Mansoura Faculty of Medicine Introduction Def: Hearing is the ability to perceive certain pressure vibrations in the
More informationHEARING SCREENING: PURE TONE AUDIOMETRY
HEARING SCREENING: PURE TONE AUDIOMETRY QUALIFIED SCREENERS 7-005.01 For the purposes of the school officials verifying that a qualified screener is carrying out the required screening activity, the qualified
More informationThe Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
More informationCorporate Medical Policy Genetic Testing for Fanconi Anemia
Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2016 3/2017 3/2016 Description
More informationSingle Gene and NextGen Panels
Molecular Testing for Hearing Loss: Single Gene and NextGen Panels Honey V Reddi, PhD, FACMG Clinical Molecular Geneticist Prevention Genetics, Marshfield, WI www.preventiongenetics.com Outline of Presentation
More informationCochlear Implantation for Children With GJB2-Related Deafness
The Laryngoscope Lippincott Williams & Wilkins, Inc. 2004 The American Laryngological, Rhinological and Otological Society, Inc. Cochlear Implantation for Children With GJB2-Related Deafness Robert D.
More informationEARLY HEARING DETECTION & INTERVENTION PROGRAM
Commissioner J. Robert Galvin, MD, MPH, MBA EARLY HEARING DETECTION & INTERVENTION PROGRAM Guidelines For Infant Hearing Screening Revised 2008 Early Hearing Detection & Intervention TABLE OF CONTENTS
More informationStatewide Infant Screening - Hearing (SWISH) Program
Guideline Department of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059 Telephone (02) 9391 9000 Fax (02) 9391 9101 http://www.health.nsw.gov.au/policies/ Statewide
More informationUnilateral (Hearing Loss in One Ear) Hearing Loss Guidance
Unilateral (Hearing Loss in One Ear) Hearing Loss Guidance Indiana s Early Hearing Detection and Intervention Program Before universal newborn hearing screening, most children with unilateral hearing loss
More informationDown s Syndrome Association Medical Series. Notes for parents & carers
An updated version of one of a series of leaflets available from the Down s Syndrome Association Down s Syndrome Association Medical Series 1. THYROID DISORDER AMONG PEOPLE WITH DOWN S SYNDROME Notes for
More informationGenetic Mutations Cause Many Birth Defects:
Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related
More informationCochlear Implant, Bone Anchored Hearing Aids, and Auditory Brainstem Implant
Origination: 06/23/08 Revised: 10/13/14 Annual Review: 11/12/15 Purpose: To provide cochlear implant, bone anchored hearing aids, and auditory brainstem implant guidelines for the Medical Department staff
More informationCHAPTER 30. MEDICAL PROVIDERS-FEE FOR SERVICE SUBCHAPTER 5. INDIVIDUAL PROVIDERS AND SPECIALTIES PART 103
CHAPTER 30. MEDICAL PROVIDERS-FEE FOR SERVICE SUBCHAPTER 5. INDIVIDUAL PROVIDERS AND SPECIALTIES PART 103. QUALIFIED SCHOOLS AS PROVIDERS OF HEALTH RELATED SERVICES 317:30-5-1023. Coverage by category
More informationDIAGNOSTIC TESTING GUIDELINES for Audiology
DIAGNOSTIC TESTING GUIDELINES for Audiology In 1999, the Illinois legislature passed the Hearing Screening for Newborns Act. By December 31, 2002, hospitals delivering babies were required to provide hearing
More informationUNIT 13 (OPTION) Genetic Abnormalities
Unit 13 Genetic Abnormailities 1 UNIT 13 (OPTION) Genetic Abnormalities Originally developed by: Hildur Helgedottir RN, MN Revised (2000) by: Marlene Reimer RN, PhD, CCN (C) Associate Professor Faculty
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationUpdate on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
More informationThyroid-Stimulating Hormone (TSH)
Thyroid-Stimulating Hormone (TSH) Table of Contents Test Overview Why It Is Done How To Prepare How It Is Done How It Feels Risks Results What Affects the Test What To Think About References Credits Test
More informationGENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110
GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic
More informationBirth defects. Report by the Secretariat
EXECUTIVE BOARD EB126/10 126th Session 3 December 2009 Provisional agenda item 4.7 Birth defects Report by the Secretariat 1. In May 2009 the Executive Board at its 125th session considered an agenda item
More informationEducation Adjustment Program (EAP) Handbook
Education Adjustment Program (EAP) Handbook Current as at September 2015 The State of Queensland (2015) This document is licensed under CC-BY 4.0, with the exception of the government coat of arms, logos
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
More informationoptimal use of thyroid function tests (TFTs) to diagnose and monitor thyroid disease.
Guidance for Thyroid Function Testing in Primary Care in Lothian In July 2006 following a lengthy consultation process, a joint working group comprising representatives from the Association of Clinical
More informationThymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
More informationAlpha-1 Antitrypsin Deficiency A future NBS candidate?
Alpha-1 Antitrypsin Deficiency A future NBS candidate? Robert A. Sandhaus, MD, PhD Alpha-1 Antitrypsin Deficiency Condition: Alpha-1 antitrypsin deficiency, alpha-1 proteinase inhibitor deficiency, Alpha-1,
More informationLife Insurance. What you need to know about. Mucopolysaccharide and related diseases including Fabry disease
Society for Mucopolysaccharide Diseases MPS House, Repton Place White Lion Road, Amersham Buckinghamshire, HP7 9LP, UK 0345 389 9901 mps@mpssociety.org.uk www.mpssociety.org.uk Mucopolysaccharide and related
More informationGuide for families of infants and children with hearing loss
With early detection, Early Intervention can begin! Guide for families of infants and children with hearing loss Birth to 3 2008 Cover photograph Geneva Marie Durgin was born January 20, 2007. She lives
More informationCorporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency
Corporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alpha_1_antitrypsin_deficiency 5/2012
More informationParents Guide To Primary Congenital Hypothyroidism
Parents Guide To Primary Congenital Hypothyroidism California Department of Health Services Genetic Disease Branch www.dhs.ca.gov/gdb To Parents: California State Law requires that all babies have the
More informationCMV: Your questions answered
The basics about the virus CMV: Your questions answered What is CMV? CMV, or Cytomegalovirus, is a common virus that can infect people of all ages. Once CMV is in a person s body, it stays there for life.
More informationWhat Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives
What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks
More informationA Guide to Otoacoustic Emissions (OAEs) for Physicians
A Guide to Otoacoustic Emissions (OAEs) for Physicians Introduction Hearing loss is not uncommon in children and adults. According to recent estimates, 31.5 million people in the United States report difficulty
More informationMolecular Genetic Testing in Public Health and Clinical Settings
Molecular Genetic Testing in Public Health and Clinical Settings Ira M. Lubin, PhD, FACMG Division of Laboratory Systems NCPDCID, CCID Centers for Disease Control and Prevention Atlanta, Georgia Disclaimers
More information